10Mizukane R,Kadota JI,YamaguchiT et al.Anelderly patient wich he-mophagocyic syndrome due to severe mycoplasma pneumoniae wich marked hyper-cytokinemia. Respiration . 2002
4[1]Ishida T,Hashimoto M,Arita I,et al.Etiology of community-acquired pneumonia in hospitalized patients:a 3-year prospective study in Japan.Chest,1998,114(6):1588-1593
5[3]Lucier TS,Heitzman K,Liu SK,et al.Transition mutations in the 23SrRNA of erythromycin-resistant isolates of Mycoplasma pneumonia.Antimicrob Agents Chemother,1995,39(12):2770-2773
7[5]Sum PE,Lee VJ,Testa RT,et al.Glycylcyclines.Ⅰ.A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.J Med Chem,1993,37(1):184-188
8[6]Goldstein FW,Kitzis MD,Acar JF.N,N-Dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline,two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.Antimicrob Agents Chemother,1994,38(9):2218-2220
9[7]Nord C,Lindmark A,Person I.In vitro activity of DMG-Mino and DMG-Dmdot,two new glycylcyclines,against anaerobic bacteria.Eur J Clin Microbiol Infect Dis,1993,12(11):784-786
10[8]Toshiyuki Y,Yoichi H,Koichi I,et al.In vitro activity of telithromycin(HMR3647),a new ketolide,against clinical isolates of Mycoplasma pneumonia in Japan.Antimicrob Agents Chemother,2000,44(5):1381-1382
